Hostname: page-component-76fb5796d-5g6vh Total loading time: 0 Render date: 2024-04-25T17:51:35.400Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Utility of Infection Control Documentation of Prior Methicillin-Resistant Staphylococcus aureus Colonization or Infection for Optimization of Empirical Antibiotic Therapy

Published online by Cambridge University Press:  02 January 2015

Marin L. Schweizer ,
Jon P. Furuno ,
Anthony D. Harris ,
Jessina C. McGregor ,
Kerri A. Thom ,
Jennifer K. Johnson ,
Michelle D. Shardell  and
Eli N. Perencevich
Marin L. Schweizer*
Affiliation:
Departments of Epidemiology and Preventive Medicine, Baltimore, Maryland
Jon P. Furuno
Affiliation:
Departments of Epidemiology and Preventive Medicine, Baltimore, Maryland
Anthony D. Harris
Affiliation:
Departments of Epidemiology and Preventive Medicine, Baltimore, Maryland
Jessina C. McGregor
Affiliation:
Oregon State University College of Pharmacy, Portland, Oregon
Kerri A. Thom
Affiliation:
Departments of Epidemiology and Preventive Medicine, Baltimore, Maryland
Jennifer K. Johnson
Affiliation:
Pathology, Baltimore, Maryland
Michelle D. Shardell
Affiliation:
Departments of Epidemiology and Preventive Medicine, Baltimore, Maryland
Eli N. Perencevich
Affiliation:
University of Maryland School of Medicine, and the Veterans Affairs Maryland Health Care System, Baltimore, Maryland
*
100 N. Greene St., Lower Level, Department of Epidemiology and Preventive Medicine, University of Maryland School of Medicine, Baltimore, Maryland, 20201 (mschweiz@epi.umaryland.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

This 5-year study of 25,378 hospitalizations measured the utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus (MRSA) colonization or infection for the optimization of empirical antibiotic therapy. Documented prior MRSA colonization or infection was predictive of subsequent MRSA infections (odds ratio, 4.05). Physicians appear to use this documentation when prescribing empirical therapy for suspected bacteremia.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 29 , Issue 10 , October 2008 , pp. 972 - 974
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Huletsky, A, Lebel, P, Picard, FJ, et al.Identification of methicillin-resistant Staphylococcus aureus carriage in less than 1 hour during a hospital surveillance program. Clin Infect Dis 2005;40:976–981.CrossRefGoogle ScholarPubMed
2.Deyo, RA, Cherkin, DC, Ciol, MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.CrossRefGoogle ScholarPubMed
3.World Health Organization. The International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9-CM). Ann Arbor: National Center for Health Statistics; 1978.Google Scholar
4.Perencevich, EN, Stone, PW, Wright, SB, et al.Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol 2007;28:1121–1133.CrossRefGoogle ScholarPubMed